Ecuador’s President Daniel Noboa wins reelection

GUAYAQUIL, Ecuador — Electoral officials in the South American country have declared President Daniel Noboa the winner of the closely run election, a little more than 3 hours after polls closed.

With more than 90 percent of the vote counted, Noboa, a close ally of President Trump has an insurmountable lead. He has been in power since November 2023 after winning a snap election.

His challenger, 47-year-old former lawmaker and lawyer Luisa González is claiming fraud, but has not produced evidence for this. The protégé of Ecuador’s exiled former leftist and polarizing leader, González told supporters in Quito the fraud was “massive” and she will fight the results and demanded a national recount.

The election took place as the country is experiencing unprecedented violence tied to the cocaine trade. Ecuador’s alarming homicide rate, one of the highest now in Latin America, weighed heavily on voters. In the first two months of this year one homicide per hour was registered.

Ecuador's President Daniel Noboa arrives with his wife Lavinia Valbonesi to address supporters at his family home in Olon, Ecuador, Sunday, April 13, 2025.
Ecuador’s President Daniel Noboa arrives with his wife Lavinia Valbonesi to address supporters at his family home in Olon, Ecuador, Sunday, April 13, 2025. (Fernando Vergara | AP)

Transnational drug cartels, working with local recruits, have turned many cities into battlegrounds as they fight for lucrative trafficking routes to the U.S. and Europe.

Noboa, the 37-year-old son of one of Ecuador’s richest men, has employed an iron fist approach to the violence, declaring a state of emergency and deploying the military.

This victory now means he has a full four year mandate to continue his self-described “war” on narco gangs. He signed a security agreement with Erik Prince, founder of the disgraced former U.S. defense contractor Blackwater and has proposed changing the constitution to allow foreign military bases in the country again.

 

FDA approves another generic abortion pill, prompting outrage from conservatives

Drugmaker Evita Solutions announced on its website that the Food and Drug Administration signed off on its low-cost form of the pill, which is approved to end pregnancies through 10 weeks.

As the shutdown drags on, the threat of permanent cuts is mired in politics

President Trump is meeting with his budget director, Russ Vought, about what additional cuts to make during the shutdown, and the president says his targets are partisan.

Pope Leo’s religious community is drawing renewed interest. Here’s what makes it unique

"Before, we might get two or three discerners. But after Pope Leo, I now have 15. It's unbelievable."

The CDC still hasn’t issued COVID vaccine guidelines, leaving access in limbo

Access to the COVID-19 vaccines remains difficult because of an unusual and unexplained delay by the Centers for Disease Control and Prevention in accepting recommendations from its advisers.

National Guard presence may deter crime, but experts warn of the long-term costs

As President Trump ramps up efforts to send federal officers and troops into cities, criminologists are watching closely. Are the feds doing this in a smart way?

Coalition raises concerns surrounding manufacturer’s environmental, labor practices in small Alabama town

The report from the Good Neighbors Alabama coalition concerns the Neptune Technology Group plant in Tallassee.

More Front Page Coverage